Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol Sandoz versus Ventolin in children with asthma
NL-OMON52633Completed
- Sponsor
- Canisius-Wilhelmina Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of salbutamol in asthma (2 arms), sponsored by Canisius-Wilhelmina Hospital. Primary endpoint: FEV1 after inhalation of 100 micrograms salbutamol. Started Mar 2023; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON52633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52633.